Subscribe Facebook Twitter Instagram
Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

FERRLECIT- sodium ferric gluconate complex injection


Prior To Ferrlecit Administration:

  • Question patients regarding any prior history of reactions to parenteral iron products.
  • Advise patients of the risks associated with Ferrlecit.
  • Advise patients to report adverse reactions associated with the use of Ferrlecit, including hypersensitivity, allergic reactions, dizziness, light-headedness, swelling, and breathing problems[seeWarnings and Precautions (5.1,5.2)andAdverse Reactions (6.1,6.2)].

Advise patients that Ferrlecit may reduce the absorption of concomitantly administered oral iron preparations[seeDrug Interactions (7)].

sanofi-aventis U.S. LLC
Bridgewater, NJ 08807
A SANOFI COMPANY

2019 sanofi-aventis U.S. LLC
Ferrlecit is a registered trademark of A. Nattermann & Cie. GmbH



Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources | Sitemap
2017 © Copyright PharmacyHQ.com. Questions?
Please contact: phq.contact@gmail.com